期刊论文详细信息
American Journal of Cancer Research
Local and systemic Curcumin C3 complex inhibits 4NQO-induced oral tumorigenesis via modulating FGF-2/FGFR-2 activation
Alok R Kh1  elwal2  Tara Moore-Medlin3 
[1] Department of Otolaryngology-Head Neck Surgery, LSU Health-Shreveport, Shreveport 71130-3932, LA, USA;Department of Pathology, LSU-Health Shreveport, Shreveport 71130-3932, LA, USA;Department of Surgery, Overton Brooks Veterans Medical Center, Shreveport 71130-3932, LA, USA
关键词: Oral squamous cell cancer;    4NQO;    Curcumin C3 complex;    FGFR-2;   
DOI  :  
学科分类:肿瘤学
来源: e-Century Publishing Corporation
PDF
【 摘 要 】

Head and Neck Squamous cell carcinoma (HNSCC) can be characterized by synchronous tumors in the upper aerodigestive tract. Second primary tumors as a result of field cancerization are a significant problem amongst patients with risk factors for HNSCC, indicating a need for chemo preventive agents. We investigated the efficacy of local and systemic Curcumin C3 complex (C3); a purified mixture of Curcumin, bisdemethoxy Curcumin and demethoxy Curcumin as a chemo preventative agent in 4-nitroquinoline-1-oxide (4NQO)-induced tumorigenesis in mice. The effect of local C3 application was compared to C3 administered orally and in combination with systemic administration. C57Bl/6 mice were administered 4NQO (50 µg/ml) in the drinking water for 16 weeks. At 12 weeks, mice were subjected to daily treatment with either vehicle (control), or 15 mg C3 complex by local delivery, gavage, or combined local and gavage for 28 days (16 week time point), and followed up to 22 weeks. Compared to local and oral systemic C3 administration, combination of local and systemic application significantly decreased multiplicity of 4NQO-induced preneoplastic and neoplastic lesions (p<0.05). Treatment with C3 correlated with a decrease in cell proliferation compared to the 4NQO group. Further, pre-treatment with C3 complex significantly attenuated 4NQO induced expression of basic fibroblast growth factor (FGF-2) and its cognate receptor FGFR-2, suggesting an important role of FGF-2/FGFR-2 axis in chemoprevention of HNSCC (p<0.05). Our findings suggest that a combination of local and systemic C3 complex could effectively target proliferation and inhibit 4NQO-induced tumorigenesis via modulation of the FGF-2/FGFR-2 axis as a mechanism for its efficacy.

【 授权许可】

CC BY-NC   

【 预 览 】
附件列表
Files Size Format View
RO201910254525365ZK.pdf 1334KB PDF download
  文献评价指标  
  下载次数:1次 浏览次数:3次